Colgate-Palmolive Company $CL Shares Purchased by Certuity LLC

Certuity LLC boosted its position in Colgate-Palmolive Company (NYSE:CL) by 106.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,628 shares of the company’s stock after purchasing an additional 5,988 shares during the period. Certuity LLC’s holdings in Colgate-Palmolive were worth $919,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of CL. Diamond Hill Capital Management Inc. lifted its position in shares of Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after acquiring an additional 2,572,796 shares during the last quarter. Amundi lifted its position in shares of Colgate-Palmolive by 41.6% during the 3rd quarter. Amundi now owns 6,294,445 shares of the company’s stock valued at $487,505,000 after acquiring an additional 1,850,412 shares during the last quarter. Two Sigma Investments LP lifted its position in shares of Colgate-Palmolive by 360.9% during the 3rd quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock valued at $169,972,000 after acquiring an additional 1,664,949 shares during the last quarter. SG Americas Securities LLC lifted its position in shares of Colgate-Palmolive by 3,896.0% during the 4th quarter. SG Americas Securities LLC now owns 1,189,005 shares of the company’s stock valued at $93,955,000 after acquiring an additional 1,159,250 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock valued at $6,633,570,000 after acquiring an additional 1,026,985 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent research reports. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 8th. Royal Bank Of Canada set a $102.00 price objective on Colgate-Palmolive in a research report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their price objective for the company from $90.00 to $98.00 in a research report on Monday, March 30th. Evercore increased their price objective on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, February 2nd. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Twelve investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $95.56.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Panagiotis Tsourapas sold 35,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the completion of the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at $985,363.15. The trade was a 77.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 184,683 shares of company stock valued at $17,486,693. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Trading Up 1.7%

Colgate-Palmolive stock opened at $85.64 on Wednesday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The company has a market capitalization of $68.71 billion, a price-to-earnings ratio of 32.69, a PEG ratio of 4.31 and a beta of 0.34. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company’s fifty day moving average price is $88.34 and its two-hundred day moving average price is $84.05.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 earnings per share. On average, analysts forecast that Colgate-Palmolive Company will post 3.85 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.5%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 80.92%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.